SQNM Surges on Positive Test Data

I've been watching Sequenom Inc (NasdaqGM: SQNM) since early June and since then the stock has run from below $10 into the $20 range.

The stock took off again pre-market today, gaining nearly 20%, or $4 on news that wides-cale tests for its pre-natal Down Syndrome test were a smashing success and will likely be launched during the first half of '09.

SQNM appears to have what will soon be become the industry standard test in a multi-billion dollar global marketplace. The stock has already shattered most analyst's aggressive price targets and will probably move higher leading up to initial shipments hitting the marketplace. Man, I wish I listened to myself and accumulated in the $5 -$10 range.